William White
Director of Finance/CFO at AKERO THERAPEUTICS, INC.
Net worth: 74 508 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Quisel | M | 53 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 4 years |
| Jonathan Young | M | 54 | 7 years | |
| Kevin Bitterman | M | 47 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| Joanne Bryce | F | 57 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| Georges Gemayel | M | 64 | 3 years | |
| Raju Mohan | M | 67 | 6 years | |
| Andrew Cheng | M | 57 | 6 years | |
| Liam Ratcliffe | M | 60 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 5 years |
| Mark Iwicki | M | 57 | 6 years | |
| Donald Nicholson | M | 67 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 5 years |
| Mark Chin | M | 42 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| William Savage | M | 50 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 4 years |
| Mona Ashiya | M | 55 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| Judy Chou | M | 58 | 3 years | |
| Graham Walmsley | M | 37 | 6 years | |
| Mike Whitaker | M | 60 | 15 years | |
| Tomas Jan Heyman | M | 68 | 4 years | |
| Yuan Xu | M | 56 | 3 years | |
| Yen Wen Yu | M | - | 4 years | |
| Onaiza Cadoret-Manier | F | 60 | 1 years | |
| Jean Franchi | F | 57 | - | |
| Timothy Rolph | M | 70 | 7 years | |
| Gary Reiner | M | 69 | 11 years | |
| Allison Hulme | M | 61 | 1 years | |
| Jane Henderson | F | 58 | 5 years | |
| Peter Henry | M | 54 | 9 years | |
| Ellen Costello | F | 69 | 8 years | |
| Seth Harrison | M | 63 | 7 years | |
| Somu Subramaniam | M | 69 | 6 years | |
| Jay Backstrom | M | 69 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 3 years |
| Renée James | F | 60 | 8 years | |
| Diana Taylor | F | 69 | 15 years | |
| James Turley | M | 68 | 11 years | |
| Duncan Hennes | M | 67 | 11 years | |
| James Goldberg | M | - | 14 years | |
| Reshma Shringarpure | F | - | 4 years | |
| Rahul Khara | M | - | - | |
| Srikanth Venkatraman | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | 7 years |
| William Joseph Mills | M | 68 | 12 years | |
| John J. Schembri | M | 62 | 5 years | |
| Patrick Lamy | M | 51 | 1 years | |
| Libette Luce | F | - | 2 years | |
| Christina Tartaglia | F | - | - | |
| Pamela Stephenson | F | 56 | - | |
| Martin Auster | M | 49 | 3 years | |
| Kitty Yale | F | 52 | 6 years | |
| Indeshaw Adenaw | M | - | 13 years | |
| Sheila Gujrathi | M | 53 | 3 years | |
| Thomas Rogers | M | - | 8 years | |
| Eric M. Snyder | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | - |
| Michael Verdeschi | M | - | 7 years | |
| Arindam Bose | M | 71 | 5 years | |
| Eric Jetter | M | - | 11 years | |
| John Nuss | M | 65 | 5 years | |
| Edward Skyler | M | 50 | 14 years | |
| Bainiaksina Julija | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian MacDonald | M | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | - |
| Aaron Royston | M | 40 | 4 years | |
| Daniel Callahan | M | 67 | 11 years | |
| John Paul Havens | M | 67 | 5 years | |
| Patrick Curtin | M | - | - | |
| Ellen Alemany | F | 68 | 20 years | |
| Lisa Maria Caputo | F | 60 | 6 years | |
| Michael Corbat | M | 63 | 9 years | |
| Michael O'Neill | M | 77 | 10 years | |
| Ned J. Kelly | M | 70 | 6 years | |
| Trang-Thu Tran | F | - | 6 years | |
| Lyndon Olson | M | 77 | 18 years | |
| Matthew R Melton | M | - | 2 years | |
| Heather Cox | F | 53 | 2 years | |
| Richard Gaster | M | 40 | 2 years | |
| Jigar Choksey | M | 38 | 2 years | |
| Deirdre Fernandes | F | 64 | 34 years | |
| Yolande Piazza | M | 55 | 11 years | |
| Lee Smallwood | M | - | 6 years | |
| William Sandborn | M | 61 | 1 years | |
| Susan Kendall | F | - | 12 years | |
| Eliza Oshana McGrath | F | - | 4 years | |
| Candida P. Wolff | F | - | - | |
| Cynthia A. Hallenbeck | F | 67 | 6 years | |
| Erik L. Hall | M | - | 13 years | |
| Timothy Collins | M | 67 | - | |
| William Samuel Thompson | M | 78 | 8 years | |
| Vikram Pandit | M | 67 | 5 years | |
| Judith Rodin | M | 79 | 13 years | |
| Lewis B. Kaden | M | 81 | 8 years | |
| Manuel Medina-Mora Escalante | M | 73 | - | |
| Jerry A. Grundhofer | M | 79 | 2 years | |
| Joan Edelman Spero | M | 79 | 5 years | |
| Alain Juan Pablo Belda Fernandez | M | 80 | 15 years | |
| Deborah Wright | F | 66 | 5 years | |
| Rohan Seneka Weerasinghe | M | 73 | 9 years | |
| Franz Humer | M | 76 | 7 years | |
| Charles O. Prince | M | 74 | 24 years | |
| Anthony Santomero | M | 78 | 10 years | |
| Michael Klein | M | 60 | 5 years | |
| Sheng Man Zhang | M | 66 | 10 years | |
| Martin Lippert | M | 64 | 1 years | |
| Richard Parsons | M | 76 | 16 years | |
| Peter L. Sheeran | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William White
- Personal Network